Polymed Biopharmaceuticals is Biotechnology in China that focus on structural biology business. Founded in 2018. They cover business area such as operator, novel therapy, oncology and auto-immune disease, innovative medicine, patient, advanced technology platform, artificial intelligence, structural biology, traditional protein inhibition, modern protein degradation.
2018
( 6 years old in 2024 )
Structural Biology
-
Office 2002, Building 4
1500 Wenyi Xi Road, Yuhang
Hangzhou, Jiangsu 311100
China
Private
operatornovel therapyoncology and auto-immune diseaseinnovative medicinepatientadvanced technology platformartificial intelligencestructural biologytraditional protein inhibitionmodern protein degradation
* We use standard office opening hours in near Polymed Biopharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Polymed Biopharmaceuticals is Biotechnology business from China that founded in 2018 (6 years old in 2024), Polymed Biopharmaceuticals business is focusing on Structural Biology.
Polymed Biopharmaceuticals headquarter office and corporate office address is located in Office 2002, Building 4 1500 Wenyi Xi Road, Yuhang Hangzhou, Jiangsu 311100 China.
Polymed Biopharmaceuticals was founded in China.
In 2024, Polymed Biopharmaceuticals is currently focus on structural biology sector.
Above is snippet of Google Trends for "structural biology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Polymed Biopharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
